Joseph T. Curti
Direttore/Membro del Consiglio presso Morehouse School of Medicine
Profilo
Joseph T.
Curti is a trustee at Morehouse School of Medicine.
He was previously the President & Chief Executive Officer at BELLUS Health, Inc. and Ferring Pharmaceuticals, Inc. He also served as a Director at Interpace Biosciences, Inc. and as President-North American Operations at Searle Research & Development.
Curti holds a doctorate degree from Thomas Jefferson University and an undergraduate degree from St. Joseph's University.
Posizioni attive di Joseph T. Curti
Società | Posizione | Inizio |
---|---|---|
Morehouse School of Medicine | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Joseph T. Curti
Società | Posizione | Fine |
---|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Presidente | 01/01/1998 |
Searle Research & Development | Corporate Officer/Principal | - |
BELLUS HEALTH | Presidente | - |
INTERPACE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | - |
Formazione di Joseph T. Curti
Thomas Jefferson University | Doctorate Degree |
St. Joseph's University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
INTERPACE BIOSCIENCES, INC. | Health Technology |
Aziende private | 3 |
---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
BELLUS Health, Inc.
BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Searle Research & Development |
- Borsa valori
- Insiders
- Joseph T. Curti